ACS Synthetic Biology · 2024 · 14 citations · 42 references
Life SciencesBiochemistryBiotechnologyEnzyme TechnologyEnzymologyMetabolic EngineeringAmino Acid ProductionBiocatalyst EngineeringCarbon FixationMetabolic Pathway EngineeringMicrobial BiocatalysisMicrobial Metabolic EngineeringAmino Acid Synthesis PathwaysAmino AcidsBiocatalytic SynthesisBiological Carbon Dioxide FixationGlycine BiosynthesisLysate-based Expression SystemsMultienzyme SystemsPhosphite Dehydrogenase Regeneration
High Resolution Image Download MS PowerPoint Slide Biological systems can directly upgrade carbon dioxide (CO 2 ) into chemicals. The CO 2 fixation rate of autotrophic organisms, however, is too slow for industrial utility, and the breadth of engineered metabolic pathways for the synthesis of value-added chemicals is too limited. Biotechnology workhorse organisms with extensively engineered metabolic pathways have recently been engineered for CO 2 fixation. Yet, their low carbon fixation rate, compounded by the fact that living organisms split their carbon between cell growth and chemical synthesis, has led to only cell growth with no chemical synthesis achieved to date. Here, we engineer a lysate-based cell-free expression (CFE)-based multienzyme biocatalyst for the carbon negative synthesis of the industrially relevant amino acids glycine and serine from CO 2 equivalents─formate and bicarbonate─and ammonia. The formate-to-serine biocatalyst leverages tetrahydrofolate (THF)-dependent formate fixation, reductive glycine synthesis, serine synthesis, and phosphite dehydrogenase-dependent NAD(P)H regeneration to convert 30% of formate into serine and glycine, surpassing the previous 22% conversion using a purified enzyme system. We find that (1) the CFE-based biocatalyst is active even after 200-fold dilution, enabling higher substrate loading and product synthesis without incurring additional cell lysate cost, (2) NAD(P)H regeneration is pivotal to driving forward reactions close to thermodynamic equilibrium, (3) balancing the ratio of the formate-to-serine pathway genes added to the CFE is key to improving amino acid synthesis, and (4) efficient THF recycling enables lowering the loading of this cofactor, reducing the cost of the CFE-based biocatalyst. To our knowledge, this is the first synthesis of amino acids that can capture CO 2 equivalents for the carbon negative synthesis of amino acids using a CFE-based biocatalyst. Looking ahead, the CFE-based biocatalyst process could be extended beyond serine to pyruvate, a key intermediate, to access a variety of chemicals from aromatics and terpenes to alcohols and polymers.
42
Microbial engineering for the production of advanced biofuels
Pamela Peralta‐Yahya, Fuzhong Zhang, Stephen B. del Cardayré et al. · Nature · 2012 · 1.1K citations
A synthetic pathway for the fixation of carbon dioxide in vitro
Thomas Schwander, Lennart Schada von Borzyskowski, Simon Burgener et al. · Science · 2016 · 708 citations · Full text
Cell-free chemoenzymatic starch synthesis from carbon dioxide
Tao Cai, Hongbing Sun, Jing Qiao et al. · Science · 2021 · 605 citations
Paolo Gabrielli, Matteo Gazzani, Marco Mazzotti · Industrial & Engineering Chemistry Research · 2020 · 548 citations · Full text
Management, Chemical Engineering, Environmental Engineering +17
Conversion of Escherichia coli to Generate All Biomass Carbon from CO2
Shmuel Gleizer, Roee Ben-Nissan, Yinon M. Bar‐On et al. · Cell · 2019 · 544 citations · Full text